Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022.
Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D. Tamargo J, et al. Among authors: dobrev d. Eur Heart J Cardiovasc Pharmacother. 2023 May 11;9(4):353-70. doi: 10.1093/ehjcvp/pvad034. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37169875 Free PMC article.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; ESC Scientific Document Group. Kirchhof P, et al. Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27. Eur Heart J. 2016. PMID: 27567408 Free article. No abstract available.
Erratum to: Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation.
Meyer-Roxlau S, Lämmle S, Opitz A, Künzel S, Joos JP, Neef S, Sekeres K, Sossalla S, Schöndube F, Alexiou K, Maier LS, Dobrev D, Guan K, Weber S, El-Armouche A. Meyer-Roxlau S, et al. Among authors: dobrev d. Basic Res Cardiol. 2017 Sep;112(5):51. doi: 10.1007/s00395-017-0638-x. Basic Res Cardiol. 2017. PMID: 28688054 No abstract available.
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A. Tamargo J, et al. Among authors: dobrev d. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):406-419. doi: 10.1093/ehjcvp/pvac005. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35092425 Review.
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P, Andreadou I, Baxter GF, Bøtker HE, Davidson SM, Dobrev D, Gersh BJ, Heusch G, Lecour S, Ruiz-Meana M, Zuurbier CJ, Hausenloy DJ, Schulz R. Ferdinandy P, et al. Among authors: dobrev d. Pharmacol Rev. 2023 Jan;75(1):159-216. doi: 10.1124/pharmrev.121.000348. Epub 2022 Dec 8. Pharmacol Rev. 2023. PMID: 36753049 Free PMC article. Review.
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023.
Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Magavern E, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D. Tamargo J, et al. Among authors: dobrev d. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):219-244. doi: 10.1093/ehjcvp/pvae013. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38379024 Review.
476 results